Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $87.11 Stock is Down 0.84 (0.96%)12/12/17 4:00 p.m. ET
Stock chart for: ANAB.O.  Currently trading at $87.11 with a 52 week high of $90.80 and a 52 week low of $15.17.
Data provided by Nasdaq. Minimum 15 minutes delayed.




Upcoming Events


  |   |   |   |   |